SANTA CLARA, Calif.--Affy metrix here has signed a three-year, nonexclusive agreement that will allow Genetics Institute to offer its DiscoverEase customers Affymetrix's GeneChip expression-monitoring probe arrays. The DiscoverEase program is a molecular biology initiative designed to build a library containing novel, human secreted proteins. Genetics Institute was a codeveloper of the GeneChip technology.
Genetics Institute said it will use the arrays to monitor expression levels of thousands of genes for identifying and selecting drug discovery research targets. It will also gain the right to develop and sell access subscriptions to a gene expression database developed using customized GeneChip probe arrays. In addition, Affymetrix agreed to supply GeneChips designed to analyze DiscoverEase genes to DiscoverEase customers.
Affymetrix will receive annual subscription fees in excess of $4 million for use of the GeneChip technology and access to related database information by Discov erEase customers. The company will also be paid custom design and per-chip fees for supplying the Disco verEase GeneChips.